Droho, Steven
Voigt, Andrew P.
Sterling, Jacob K.
Rajesh, Amrita
Chan, Kyle S.
Cuda, Carla M.
Perlman, Harris
Lavine, Jeremy A.
Funding for this research was provided by:
Illinois Society for the Prevention of Blindness
Rheumatology Research Foundation (Innovative Research Award)
National Institute of Allergy and Infectious Diseases (AI170938)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR075423)
National Institute on Aging (AG049665)
National Cancer Institute (CA060553)
Northwestern University (Mabel Greene Myers Professor of Medicine)
Research to Prevent Blindness (Sybil B. Harrington Career Development Award for Macular Degeneration)
National Eye Institute (EY030923)
Article History
Received: 8 August 2023
Accepted: 10 October 2023
First Online: 19 October 2023
Declarations
:
: All experiments were approved by the Northwestern University Institutional Animal Care and Use Committee, and adhere to the ARVO statement for the Use of Animals in Ophthalmic and Vision Research.
: Not applicable.
: JAL is a consultant for Line 6 Biotechnology and Genentech, which are completely unrelated to this current manuscript. The authors declare no competing interests.